MGC Diagnostics Corporation (NASDAQ:MGCD) posted its quarterly earnings data on Wednesday, September 6th. The medical equipment provider reported $0.17 earnings per share for the quarter, Bloomberg Earnings reports. The company had revenue of $10.41 million during the quarter. MGC Diagnostics Corporation had a positive return on equity of 3.49% and a negative net margin of 8.85%.
Shares of MGC Diagnostics Corporation (NASDAQ MGCD) traded up 1.62% on Wednesday, reaching $8.13. The company had a trading volume of 2,448 shares. The stock’s market cap is $35.85 million. The stock has a 50-day moving average price of $7.99 and a 200-day moving average price of $8.31. MGC Diagnostics Corporation has a 12 month low of $6.24 and a 12 month high of $10.60.
WARNING: “MGC Diagnostics Corporation (MGCD) Posts Earnings Results” was originally reported by Week Herald and is the property of of Week Herald. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://weekherald.com/2017/09/13/mgc-diagnostics-corporation-mgcd-issues-earnings-results.html.
MGC Diagnostics Corporation Company Profile
MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs).
Receive News & Ratings for MGC Diagnostics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MGC Diagnostics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.